Skip to main content

Closed

NGEN: NervGen Pharma Corp. Common stock Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-719.6%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio1.16×

NervGen Pharma Corp. Common stock

NGENNASDAQ Capital Market·USD·Closed

NervGen Pharma Corp. Common stock

NGENNASDAQ·USD·Closed

$1.62

+1.25%

$1.62

+$0.02 (1.25%)

52W Range

1thpctl

Volume

0.31×avg

Mkt Cap

133.15MUSD

P/E

-8.4TTM

Div Yield

–ann

52W Range

1thpctl

Volume

0.31×avg

Market Cap

133.15MUSD

P/E Ratio

-8.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings